Vanda Pharmaceuticals (VNDA) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Vanda Pharmaceuticals (VNDA) over the last 14 years, with Q4 2024 value amounting to $11.6 million.
- Vanda Pharmaceuticals' Accumulated Depreciation & Amortization rose 345.23% to $11.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $11.6 million, marking a year-over-year increase of 345.23%. This contributed to the annual value of $11.6 million for FY2024, which is 345.23% up from last year.
- As of Q4 2024, Vanda Pharmaceuticals' Accumulated Depreciation & Amortization stood at $11.6 million, which was up 345.23% from $11.2 million recorded in Q4 2023.
- Over the past 5 years, Vanda Pharmaceuticals' Accumulated Depreciation & Amortization peaked at $11.6 million during Q4 2024, and registered a low of $8.0 million during Q4 2020.
- Over the past 5 years, Vanda Pharmaceuticals' median Accumulated Depreciation & Amortization value was $10.4 million (recorded in 2022), while the average stood at $10.1 million.
- Per our database at Business Quant, Vanda Pharmaceuticals' Accumulated Depreciation & Amortization surged by 2141.56% in 2020 and then soared by 345.23% in 2024.
- Vanda Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $8.0 million in 2020, then increased by 16.8% to $9.4 million in 2021, then grew by 11.11% to $10.4 million in 2022, then rose by 7.31% to $11.2 million in 2023, then grew by 3.45% to $11.6 million in 2024.
- Its Accumulated Depreciation & Amortization was $11.6 million in Q4 2024, compared to $11.2 million in Q4 2023 and $10.4 million in Q4 2022.